<DOC>
	<DOCNO>NCT00641472</DOCNO>
	<brief_summary>A one year study compare safety effectiveness Pulmicort ( 0.5mg strength give day even ) either 4 5mg strength SINGULAR ( give day even ) child asthma age 2 8 . If allocate SINGULAR treatment , child age 2 5 receive 4mg strength SINGULAR age 6 8 receive 5mg strength SINGULAR .</brief_summary>
	<brief_title>Pulmicort Respules ( Budesonide Inhalation Suspension ) v Singulair , Children</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Aged 2 8 study entry At least 3 episode wheeze previous year last 24 hour affect sleep symptom mild persistent asthma use b2 agonist treatment least 3 7 consecutive day run Severe unstable asthma significant finding physical exam exacerbation asthma 30 day enter study might affect study result judgement study doctor</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Pulmicort</keyword>
	<keyword>Children</keyword>
	<keyword>paediatrics</keyword>
	<keyword>budesonide</keyword>
</DOC>